Investigation of the Triglyceride/Glucose Index in Diabetic Patients Using SGLT-2 Inhibitor
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 55
- 试验地点
- 1
- 主要终点
- Change in triglyceride index
研究概览
简要总结
This study was designed to evaluate the change in triglyceride glucose index, one of the atherosclerotic markers, in patients with type 2 DM followed in the Internal Medicine Clinic of Samsun University, Samsun Training, and Research Hospital.
Methods: The data of the patients who were followed up for at least 3 months by making a retrospective file review will be recorded and analyzed. It is planned to start the study following the ethics committee's approval.
详细描述
The data of all patients who applied to Samsun Training and Research Hospital Internal Medicine outpatient clinic for 12 months in 2022 and were started on SGLT-2 inhibitor will be examined. According to the inclusion and exclusion criteria stated below, the patients will be evaluated and the data of the patients admitted to the study will be analyzed. The triglyceride glucose index of the patients before starting the SGLT-2 injection and the trig/glucose index at the end of 3 months of treatment will be calculated by the researchers using the data in the system. No additional blood tests or laboratory analyses will be performed on the patients. Triglyceride, glucose, and glycosylated hemoglobin values were checked at the beginning of the treatment and at the 3rd-month follow-up.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 DM
- •Age >18 years old
- •Dapagliflozin 10 mg or empagliflozin 10 mg or 25 mg
- •3 months follow-up period
排除标准
- •Type 1 diabetes
- •Gestational diabetes
- •Age < 18 years old
- •Insufficient or missed laboratory test results
- •Medical treatment for dyslipidemia
- •Hypothyroidism
结局指标
主要结局
Change in triglyceride index
时间窗: 3 months
Decreased triglyceride index among patients using SGLT-2 inhibitors.
次要结局
未报告次要终点
研究者
Duriye Sila Karagoz Ozen
MD,Internal Medicine Specialist
Samsun Education and Research Hospital